Key facts
- This page summarizes Larry Kaiser's Form 4 filing for Medicus Pharma Ltd. (MDCX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Nov 2026, 17:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
On November 13, 2026, Larry Kaiser entered into a subscription agreement with the Issuer, pursuant to which Mr. Kaiser agreed to purchase 14,534 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.